VLNS logo

VLNS The Valens Company Inc.

NASDAQ Capital Market · Drug Manufacturers - Specialty & Generic · Healthcare

$0.76
+0.00 (+0.00%)

The Valens Company Inc. is engaged in the development, manufacturing, and global distribution of cannabinoid-derived products, serving both Canadian and international markets. Their offerings include biomass products from dried cannabis and hemp. Additionally, they provide an extensive range of finished goods such as tinctures, various capsules (two-piece and soft gels), oral sprays, and vape pens…

Market Cap: $61.46Mwww.thevalenscompany.com

Price

No data yet.

Social Signal Score

48
5d
—
30d
48
2 mentions
—
60d
47
3 mentions
—
90d
48
5 mentions
—
news: 5

Company Profile

CEO
Jeffrey Fallows CFA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
445
Beta
0.00
Country
CA
www.thevalenscompany.com